PRKN and Parkinson disease: Importantly, the activation of the cGAS/STING pathway by circular cell-free mtDNA release, measured as an increase in proinflammatory Interleukin 6 (Il-6) levels has been confirmed in Parkinson’s disease patients with PARK2/PARK6 mutations.